TLR5 and asthma: Additionally, activation of TLR5 has been found to exacerbate airway inflammation in asthma (178, 179), whereas the regulatory DCs (rDCs) and Tregs can suppress TH1/TH2/TH17 responses in a TLR5-dependent manner, thereby inhibiting the development of experimental asthma (180).